2 results
Approved WMOCompleted
To evaluate the safety and efficacy of abicipar (2 mg), compared to 0.5 mg ranibizumab in treatment-naïve patients with neovascular AMD.
Approved WMORecruiting
The primary objective is to evaluate the difference in 68Ga-exendin tracer accumulation in the pancreas of women with and without a history of GDM by quantitative analysis of PET images.